Skip to content

Augmedix, Inc.

Delisted

CIK 1769804fmd_1621QNF0Z8Z5257M3ETPE7XTH2Services · Services-Business Services, NECTemplate: Standard

Coverage: Jan 01, 2019 to Jun 30, 2024, 22 periods

Latest annual · FY2023

Millions
Total revenues
45
Gross profit
22
Operating income
(19)
Net income
(19)
Free cash flow
(19)

Latest quarter · Q2 FY2024

Millions
Total revenues
14
Gross profit
6
Operating income
(9)
Net income
(8)
Free cash flow
(4)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2023
+39.6%

Augmedix, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Revenue$44.9 million$30.9 million+45%10-K 2024-03-26 · proof
Gross profit$21.5 million$14 million+54.3%10-K 2024-03-26 · proof
Operating income-$18.8 million-$22.4 million10-K 2024-03-26 · proof
Net income-$19.2 million-$24.4 million10-K 2024-03-26 · proof
Cash from operating activities-$15.4 million-$16.8 million10-K 2024-03-26 · proof
Free cash flow-$18.5 million-$18.2 million10-K 2024-03-26 · proof
Total assets$66.7 million$33.6 million+98.3%10-K 2024-03-26 · proof
Total liabilities$43.4 million$32.2 million+34.9%10-K 2024-03-26 · proof
Cash and cash equivalents$46.2 million$21.3 million+117.5%10-K 2024-03-26 · proof
What was Augmedix, Inc.'s revenue in fiscal 2023?
Augmedix, Inc. reported revenue of $44.9 million for fiscal 2023 (the year ended Dec 31, 2023), against $30.9 million the year before (+45%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What was Augmedix, Inc.'s gross profit in fiscal 2023?
Augmedix, Inc. reported gross profit of $21.5 million for fiscal 2023 (the year ended Dec 31, 2023), against $14 million the year before (+54.3%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What was Augmedix, Inc.'s operating income in fiscal 2023?
Augmedix, Inc. reported operating income of -$18.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$22.4 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What was Augmedix, Inc.'s net income in fiscal 2023?
Augmedix, Inc. reported net income of -$19.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$24.4 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What was Augmedix, Inc.'s cash from operating activities in fiscal 2023?
Augmedix, Inc. reported cash from operating activities of -$15.4 million for fiscal 2023 (the year ended Dec 31, 2023), against -$16.8 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What was Augmedix, Inc.'s free cash flow in fiscal 2023?
Augmedix, Inc. reported free cash flow of -$18.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$18.2 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What are Augmedix, Inc.'s total assets?
As of Dec 31, 2023, Augmedix, Inc. reported total assets of $66.7 million, against $33.6 million a year earlier (+98.3%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What are Augmedix, Inc.'s total liabilities?
As of Dec 31, 2023, Augmedix, Inc. reported total liabilities of $43.4 million, against $32.2 million a year earlier (+34.9%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
What are Augmedix, Inc.'s cash and cash equivalents?
As of Dec 31, 2023, Augmedix, Inc. reported cash and cash equivalents of $46.2 million, against $21.3 million a year earlier (+117.5%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1769804&period_type=annual&limit=5"

Information only, not investment advice.